Department of Health Management and Policy, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.
Division of General Internal Medicine and Geriatrics, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Health Serv Res. 2022 Aug;57(4):863-871. doi: 10.1111/1475-6773.13953. Epub 2022 Feb 28.
To examine the effects of Medicare Advantage (MA) enrollment on patterns of end-of-life care.
We used data from the Master Beneficiary Summary File, the Medicare Provider Analysis and Review, hospice claims, the Minimum Data Set, the Outcome and Assessment Information Set, the Area Health Resources File, and Geographic Variation Public Use File for 2012-2014.
To address selective enrollment into MA, we exploited a discontinuity in payment rates by county population (urban floor payments) as an instrument.
DATA COLLECTION/EXTRACTION METHODS: We identified Medicare beneficiaries continuously enrolled in MA or TM during their last year of life between 2012 and 2014 using Medicare administrative data.
We did not find evidence that MA enrollment led to a change in hospital admissions in the last 30 days of life, but MA enrollment decreased hospital as the site of death by 11.0 (95% CI: -13.9 to -8.1) percentage points. Once hospitalized, however, MA enrollment increased use of intensive care by 6.7 (95% CI: 0.3 to 13.1) percentage points and non-invasive mechanical ventilation by 9.2 (95% CI: 5.5 to 12.9) percentage points. MA enrollment increased hospice use by 6.2 (95% CI: 2.3 to 10.1) percentage points at time of death and 7.7 (95% CI: 3.8 to 11.6) percentage points in the last 30 days of life. Particularly, MA enrollment increased hospice admissions among those who were admitted to the hospital within 30 days prior to hospice admission by 18.8 (95% CI: 13.8 to 23.8) percentage points. However, MA enrollment decreased hospice admissions among those who were admitted to home health within 30 days prior to hospice admission by 18.6 (95% CI: -21.9 to -15.2) percentage points.
MA plans may improve end-of-life care by reducing hospital death while also improving access to hospice, especially among recently hospitalized persons.
考察医疗保险优势计划(MA)参保对临终关怀模式的影响。
我们使用了 2012 年至 2014 年主受益摘要文件、医疗保险提供者分析和审查、临终关怀索赔、最低数据集、结果和评估信息集、区域卫生资源文件和地理差异公共使用文件的数据。
为了解决选择性参加 MA 的问题,我们利用了按县人口(城市下限支付额)划分的支付率的不连续性作为工具。
资料收集/提取方法:我们使用医疗保险管理数据,确定了在 2012 年至 2014 年期间最后一年持续参加 MA 或 TM 的 Medicare 受益人。
我们没有发现 MA 参保导致生命最后 30 天住院人数变化的证据,但 MA 参保将死亡地点从医院减少了 11.0(95%置信区间:-13.9 至-8.1)个百分点。然而,一旦住院,MA 参保使重症监护的使用率增加了 6.7(95%置信区间:0.3 至 13.1)个百分点,非侵入性机械通气增加了 9.2(95%置信区间:5.5 至 12.9)个百分点。MA 参保使临终时的临终关怀使用率增加了 6.2(95%置信区间:2.3 至 10.1)个百分点,生命最后 30 天的使用率增加了 7.7(95%置信区间:3.8 至 11.6)个百分点。特别是,MA 参保使在临终关怀入院前 30 天内住院的人中,临终关怀入院的人数增加了 18.8(95%置信区间:13.8 至 23.8)个百分点。然而,MA 参保使在临终关怀入院前 30 天内接受家庭健康护理的人中,临终关怀入院的人数减少了 18.6(95%置信区间:-21.9 至-15.2)个百分点。
MA 计划可能通过降低医院死亡率来改善临终关怀,同时增加临终关怀的可及性,特别是在最近住院的人群中。